G 367 Pill - beige gray capsule/oblong, 14mm
Pill with imprint G 367 is Beige / Gray, Capsule/Oblong and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Glenmark Pharmaceuticals Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 367
Topiramate Extended-Release
- Imprint
- G 367
- Strength
- 25 mg
- Color
- Beige / Gray
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0372
Related images for "G 367"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,337)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.